News
A new bill could make the price of prescription drugs known for weight loss cheaper for the state to buy for its employees. The bill would eliminate pharmacy benefit ...
Novo Nordisk cut ties with Hims & Hers, accusing the telehealth firm of promoting Wegovy copycat versions of the weight-loss ...
GLP-1 drugs like semaglutide and tirzepatide show promise in treating obesity, with benefits including weight loss and ...
Eli Lilly receives approval for Mounjaro in prefilled Kwikpen as competition intensifies in India's weight-loss drug market ...
A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may ...
Novo Nordisk shares have come under pressure amid weight-loss drug competition, while UK health officials have launched a ...
9hon MSN
Data show over 100 deaths have been linked to weight loss jabs approved by the NHS, with drugs like Ozempic, Wegovy and ...
For the first time, 40-year-old Manmeet Bindra feels motivated to exercise and has set up a home gym, cleaned up her diet and ...
As a mass rollout of weight loss injections begins across the NHS, with GPs able to prescribe Mounjaro for the first time ...
Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as unsettled as ever.
The FDA says semaglutide is no longer in shortage. Local pharmacies aren't sure that's a good thing.
DALLAS — With the active ingredient behind such popular weight-loss medications as Ozempic and ... Pharmacies can compound semaglutide for pennies to a few dollars per month, making the drugs more ...
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results